This is is part of my live-learning series! I will be updating this post as I continue through my journey. I apologize for any grammatical errors or incoherent thoughts. This is a practice to help me share things that are valuable without falling apart from the pressure of perfection.
It’s a wild time to invest in alternative medicine — just think about how much wealth has come from the widespread legalization of CBD and expanded access to full-spectrum cannabis in recent years. As we observe the successes and failures from these first-wave ventures, investors are now identifying a natural link to the early (yet potentially explosive) world of commercial psychedelics.
Why? Similarly to how people are using cannabis and CBD to treat themselves, these compounds are positioned to become the next big thing in mental health treatment.
Psilocybin, LSD and MDMA are being recommended as potential treatments for anxiety, depression and C/PTSD by a growing number of reputable institutions, with research indicating that these compounds could also have far-reaching effects for people struggling with substance abuse, smoking addiction or processing grief. The psychedelic-psychiatric breakthrough happens when you take one of these drugs, resulting in a dissolution of the ego, which can lead to a new perception of reality and one’s place within it.”
Thanks so much for checking this out. I’ll be back to improve this content for you.
Give me a text or call at (647) 372-1565
Easily book a meeting with Calendly
“A group of Silicon Valley and Wall Street executives has raised $30 million to speed the development of a closely watched psychedelic-drug therapy using the
This is is part of my live-learning series! I will be updating this post as I continue through my journey. I apologize for any grammatical
I'd love if you subscribed today. I promise I will only send you great, valuable content that has transformed me and helped others flourish.